When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.

Novartis researchers aim to quash inflammation to treat chronic disease.

Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

In the ever-evolving world of STEM, where innovation and discovery are to the forefront, the stories of women who have made their mark are both inspiring and essential. Today, we're shining a spotlight on two dedicated Novartis employees who have chosen to begin their careers in manufacturing operations, paving the way for others to follow.

What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.

Up the stairs to the entrance of the plane they climb: small children with cloudy eyes, teens with thick glasses and practiced squints, adults with dark shades.

Paul Aliu and his team quickly address requests for Novartis medicines during the pandemic.

Healthcare expert Dr. Jonathan D. Quick discusses solutions to address the rapid rise of chronic illnesses in the developing world.

With extensive experience in public health management, having worked for the International Red Cross, among others, and as a doctor in emergency situations on the ground in Africa and Asia— Ann Aerts discusses the Novartis Foundation's new leprosy strategy.